Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013)

Prothena Corp Public (PRTA) recorded quarterly Non-Current Deferred Tax Liability of $201000.0 in Q2 2013.

Prothena Corp Public (PRTA) Non-Current Deferred Tax Liability (2013) Analysis & Trends

Prothena Corp Public's Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $201000.0 for Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Prothena Corp Public	479.08 Mn	149.61 Mn	-

Download Data

Date	Value
Jun 30, 2013	201,000.00
Jun 30, 2013	201,000.00